Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis.

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

This was the case for Nefa-Tari Moore, 45, a three time "thriver" of gynecological cancer. The blood test for CA-125, a ...

A new study focusing on the common CA-125 blood test found that some patients were 23 percent less likely to show elevated cancer antigen levels at diagnosis.

The study, published in JAMA Network Open, looked at more than 200,000 women with ovarian cancer who took a test called ...

Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

About The Study: In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis. Current ...

A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood ...